Biontech Se ADR (BNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 3,401,715 | 7,153,576 | 6,407,428 | 7,178,144 | 6,396,211 |
| Cost of Goods | 813,687 | 1,452,239 | 670,197 | 1,428,483 | 1,064,891 |
| Gross Profit | 2,588,028 | 5,701,337 | 5,737,230 | 5,749,661 | 5,331,321 |
| Operating Expenses | 237,259 | 368,096 | 287,715 | 180,193 | 273,560 |
| Operating Income | 2,351,456 | 5,333,480 | 5,449,712 | 5,569,951 | 5,058,652 |
| Interest Expense | 6,172 | 7,519 | -2,388 | 97,520 | 211,942 |
| Other Income | 122,915 | 305,351 | 18,470 | 31,367 | 362 |
| Pre-tax Income | 2,468,199 | 5,631,312 | 5,470,570 | 5,503,798 | 4,847,072 |
| Income Tax | 688,857 | 1,480,518 | 1,798,258 | 1,717,387 | 1,488,774 |
| Net Income Continuous | 1,779,342 | 4,150,793 | 3,672,312 | 3,786,411 | 3,358,297 |
| Net Income | $1,779,342 | $4,150,793 | $3,672,311 | $3,786,411 | $3,358,297 |
| EPS Basic Total Ops | 7.30 | 16.98 | 15.05 | 15.49 | 13.76 |
| EPS Basic Continuous Ops | 7.30 | 16.98 | 15.06 | 15.49 | 13.76 |
| EPS Diluted Total Ops | 6.86 | 15.98 | 14.05 | 14.56 | 12.98 |
| EPS Diluted Continuous Ops | 6.86 | 15.98 | 14.06 | 14.56 | 12.98 |
| EBITDA(a) | $2,385,187 | $5,364,453 | $5,480,665 | $5,592,544 | $5,078,403 |